Drug Trial Radar · NCT01373151
Phase IIB Rheumatoid Arthritis Dose Ranging Study for BMS-945429 in Subjects Who Are Not Responding to Methotrexate
Last checked: Nov 20, 2026Latest source record: Dec 6, 2021 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
418
Actual
Start
Jun 2011
Primary completion
Sep 2012
Study completion Jun 2015
Sponsor
- Lead sponsor
- CSL BehringIndustry
- Sponsor type
- Industry
- First posted
- Jun 14, 2011
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to determine the effective dose of BMS-945429 in subjects with inadequate response to Methotrexate in the treatment of moderate to severe Rheumatoid Arthritis.
Conditions
- Rheumatoid Arthritis
Interventions
BMS-945429 PlaceboDrug
Injection, Subcutaneous, 0 mg, Every 4 weeks, Day 1 - Week 24 only
BMS-945429Biological
Injection, Subcutaneous, 25 mg, Every 4 weeks, Day 1 - Week 24 only
BMS-945429Biological
Injection, Subcutaneous, 100 mg, Every 4 weeks, 48 weeks
BMS-945429Biological
Injection, Subcutaneous, 200 mg, Every 4 weeks, Week 25 - Week 48
BMS-945429Biological
Injection, Subcutaneous, 200 mg, Every 4 weeks, 48 weeks
MethotrexateDrug
Tablets, Oral, 15 mg, Weekly, Day 1 - Week 24 only
MethotrexateDrug
Tablets, Oral, 15 mg, Weekly, 48 weeks
Methotrexate PlaceboDrug
Tablets, Oral, 0 mg, Weekly, Day 1 - Week 24 only
MethotrexateDrug
Tablets, Oral, 15 mg, Weekly, Week 25 - Week 48 only
Adalimumab PlaceboDrug
Injection, Subcutaneous, 0 mg, Every 2 weeks, 48 weeks
AdalimumabDrug
Injection, Subcutaneous, 40 mg, Every 2 weeks, 48 weeks
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percent of Participants Achieving an American College of Rheumatology (ACR) 20% Response RateTime frame: At 12 Weeks
Locations
100 sites in 19 countries. Site status is shown where the registry gives one.
Sun Valley Arthritis Center, Ltd.
Peoria, Arizona
San Diego Arthritis Medical Clinic
San Diego, California
New England Research Associates, Llc
Trumbull, Connecticut
Quincy Medical Group
Quincy, Illinois
Rockford Orthopedic Associates, Llc.
Rockford, Illinois
Clinical Pharmacology Study Group
Worcester, Massachusetts
Arthritis Associates Of Mississippi
Jackson, Mississippi
Physician Research Collaboration, Llc
Lincoln, Nebraska
Box Arthritis And Rheumatology Of The Carolinas, Pllc
Charlotte, North Carolina
Health Research Of Oklahoma
Oklahoma City, Oklahoma
East Penn Rheumatology Associates, P.C.
Bethlehem, Pennsylvania
Altoona Center For Clinical Research
Duncansville, Pennsylvania
Seattle Rheumatology Associates
Seattle, Washington
Local Institution
Córdoba, Argentina
Local Institution
San Juan, Argentina
Local Institution
Capital Federal, Buenos Aires, Argentina
Local Institution
Capital Federal, Buenos Aires, Argentina
Local Institution
Capital Federal, Buenos Aires, Argentina
Local Institution
Capital Federal, Buenos Aires, Argentina
Local Institution
Rosario, Santa Fe Province, Argentina
Local Institution
San Miguel de Tucumán, Tucumán Province, Argentina
Local Institution
Brussels, Belgium
Local Institution
Hasselt, Belgium
Local Institution
São Paulo, Brazil
Local Institution
São Paulo, Brazil
Local Institution
Goiânia, Goiás, Brazil
Local Institution
Juiz de Fora, Minas Gerais, Brazil
Local Institution
Curitiba, Paraná, Brazil
Local Institution
Curitiba, Paraná, Brazil
Local Institution
Porto Alegre, Rio Grande do Sul, Brazil
Local Institution
Montreal, Quebec, Canada
Local Institution
Québec, Quebec, Canada
Centre De Recherche Musculo-Squelettique
Trois-Rivières, Quebec, Canada
Local Institution
Prague, Czechia
Local Institution
Prague, Czechia
Local Institution
Bordeaux, France
Local Institution
Chambray-lès-Tours, France
Local Institution
Strasbourg, France
Local Institution
Berlin, Germany
Local Institution
Cologne, Germany
Showing 40 of 100 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.